blog-1-1

Your healthcare provider will tell you when and how often to take your medication (usually injections). Be sure to follow their instructions. But, in general, the frequencies of the injections are: Dulaglutide: Once a week. Exenatide: Twice a day. Exenatide extended-release: Once a week. Liraglutide: Once a day. Lixisenatide: Once a day. Semaglutide: Once a […]

Other than lowering blood sugar levels and reducing weight, studies show that GLP-1 agonists may have other potential benefits, like: Lowering blood pressure. Improving lipid disorders. Improving fatty liver disease. Reducing your risk of heart disease and kidney disease. Delaying the progression of diabetes-related nephropathy.

The most common side effects of GLP-1 agonists include: Loss of appetite. Nausea. Vomiting. Diarrhea. These side effects are more likely to happen when you start the medication or if you’re taking an increased dose. Other side effects can include: Dizziness. Mild tachycardia (increased heart rate). Infections. Headaches. Indigestion (upset stomach). You may also have

GLP-1 agonists are generally safe. But there are a few risks to consider, including: Allergic reactions. Use during pregnancy. Low blood sugar (hypoglycemia). Pharmacy near me RX medication delivery

There’s a low risk of mild low blood sugar (hypoglycemia) episodes if you take a GLP-1 agonist. It can become a serious risk if you take GLP-1s with other medications that lower blood sugar, like sulfonylureas or insulin. Hypoglycemia is blood sugar that’s lower than 70 mg/dL. Without proper treatment, severe hypoglycemia can be life-threatening.

GLP-1 agonists aren’t safe to take during pregnancy. Animal studies show that these medications cause developmental abnormalities in the fetus. If you’re able to become pregnant, you should use effective and reliable birth control while taking a GLP-1 agonist. If you become pregnant while taking the medication, see your healthcare provider immediately.

Medications are often used off label when they are found to have properties or effects that could potentially benefit a disease state or condition they were not originally intended for. Up to one-third of all prescriptions for common medications in the United States are used off label.1 Glucagon-like peptide 1 (GLP-1) receptor agonists are a

GLP-1 is an incretin hormone that is released from the distal ileum in the small intestine and the colon within minutes of ingesting food. It has been shown to decrease glucagon secretion, increase glucose uptake and glycogen synthesis in the peripheral tissues, delay gastric emptying, and increase satiety.4 GLP-1 was first discovered in 1987 by

Originally developed to improve glycaemic control in patients with type 2 diabetes, GLP-1 receptor agonists have emerged as promising agents for weight management and cardiovascular protection, expanding their therapeutic potential beyond diabetes care.1 Since 2016, clinical trials such as LEADER,2 SELECT,3 and SURPASS4 have demonstrated the cardiovascular benefits of GLP-1 receptor agonists, consistently showing a

Along with helping to control blood sugar and boosting weight loss, GLP-1 agonists and SGLT-2 inhibitors seem to have other health benefits. Research has found that some of these medicines may lower the risk of certain serious health conditions, such as kidney disease, heart disease, heart failure and stroke. Many people who take these medicines